thymopentin has been researched along with Candidiasis, Oral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angarano, G; Buccoliero, G; Coppola, S; Guida, G; Laddago, V; Monno, L; Perrone, A; Schiraldi, O | 1 |
1 trial(s) available for thymopentin and Candidiasis, Oral
| Article | Year |
|---|---|
Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: a pilot study.
Topics: Adjuvants, Immunologic; Administration, Inhalation; AIDS-Related Opportunistic Infections; Candida albicans; Candidiasis, Oral; Humans; Immunoglobulin A, Secretory; Leukocyte Count; Pilot Projects; Saliva; Thymopentin | 1996 |